Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
about
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic reviewSequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II studyPhase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphomaNucleoside analogues in the treatment of haematological malignancies.Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer.Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine modelPhase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma: a phase II multicenter trial.First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.
P2860
Q24678961-1D5C4A5D-06E7-46E2-AA5D-3CF811E5C854Q33289242-03119BA6-AC96-47C8-ADF1-835892CE080BQ33340710-E9D3D670-9148-40EC-AC76-5CEDC4803912Q33341208-1633346F-E97A-4837-B3D6-EE6A4BE0C555Q33343275-31589788-190D-497D-87D3-B3EC8A294055Q34064220-6B7B329F-49AD-41F1-BF5D-44EEDCA07AC0Q34390281-6922F638-4D37-4BAF-9972-A80534739142Q36621872-467B04AB-B30D-4F98-BD98-77D87ED26D32Q36695414-38A403BA-F573-47C8-8FC3-953653281332Q36980421-56F6669A-3D80-4156-AE4E-FD2DD6EE8A5AQ37157395-066FC7EA-946D-45C8-980E-5ABB1F8AEF5EQ43732866-BDFF045A-D5AF-44A3-BACA-5C9598476B29Q44003032-FD996CEC-57E6-4CF3-BC12-6625F5E675D1
P2860
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@ast
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@en
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@nl
type
label
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@ast
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@en
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@nl
prefLabel
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@ast
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@en
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@nl
P2093
P1476
Phase I/II study of gemcitabin ...... of non-small-cell lung cancer.
@en
P2093
C Brunetti
F Carpagnano
G Di Rienzo
M L Cisternino
P304
P356
10.1200/JCO.2000.18.2.405
P407
P577
2000-01-01T00:00:00Z